研究用フローサイトと理化学分析

世界のリサーチ分野のお客さまへ先端の検査装置のご案内です。

お問い合わせはこちら

sysmex

研究用フローサイトと理化学分析sysmex

CyFlow CD62L FITC

品番 AX041427
抗体名 Anti-Ms CD62L FITC,MEL-14
包装単位 0.1 mg
濃度 0.5 mg/ml
容量 0.2 ml
関連製品
(アイソタイプコントロール)
-
反応性|交差吸着 Mouse レーザー Blue
抗原 CD62L, L-selectin 最大蛍光波長 518 nm
クローン MEL-14 最大励起波長 490 to 495 nm
ホスト Rat 標識/Format FITC
アイソタイプ IgG2a 研究分野 Immunophenotyping | MHC
クローナリティ monoclonal 用途

Flow cytometry

Anti-Ms CD62L FITC,MEL-14

特異性

The rat monoclonal antibody MEL-14 recognizes mouse CD62L, a 75 kDa single chain type I glycoprotein expressed on most peripheral blood B lymphocytes, T lymphocytes, monocytes and granulocytes; it is also present on a subset of NK cells and certain hematopoietic malignant cells.

抗原情報

CD62L (L-selectin) is an adhesion glycoprotein that is constitutively expressed on the cell surface of leukocytes and mediates their homing to inflammatory sites and peripheral lymph nodes by enabling rolling along the venular wall. CD62L is also involved in activation-induced neutrophil aggregation. Activation-dependent CD62L shedding, however, counteracts neutrophil rolling. CD62L has also signaling roles including enhance of chemokine receptor expression. Similarly to CD62P, the major ligand of CD62L is PSGL-1 (P-selectin glycoprotein ligand-1).

利用方法

The reagent is designed for Flow Cytometry analysis. Suggested working usage is 6 µg/ml. Indicated dilution is recommended starting point for use of this product, but working concentrations should be validated by the investigator.

保存方法

Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.

安定性情報

Do not use after expiration date stamped on vial label.

レファレンス

• Brawand P, Cerottini JC, MacDonald HR: Hierarchal utilization of different T‑cell receptor Vbeta gene segments in the CD8(+)‑T‑cell response to an immunodominant Moloney leukemia virus‑encoded epitope in vivo. J·Virol. 1999·Nov; 73(11):9161‑9. <·PMID:·10516023·>
• Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ: Transfer of allogeneic CD62L‑ memory T cells without graft‑versus‑host disease. Blood. 2004·Feb·15; 103(4):1534‑41. <·PMID:·14551132·>
• Chin CS, Miller CH, Graham L, Parviz M, Zacur S, Patel B, Duong A, Bear HD: Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L‑selectinlow tumor‑sensitized lymphocytes. Int·Immunol. 2004·Sep; 16(9):1283‑94. <·PMID:·15262898·>
• Fisson S, Darrasse-Jèze G, Litvinova E, Septier F, Klatzmann D, Liblau R, Salomon BL: Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J·Exp·Med. 2003·Sep·1; 198(5):737‑46. <·PMID:·12939344·>
• Friedline RH, Wong CP, Steeber DA, Tedder TF, Tisch R: L‑selectin is not required for T cell‑mediated autoimmune diabetes. J·Immunol. 2002·Mar·15; 168(6):2659‑66. <·PMID:·11884430·>
• Gallatin WM, Weissman IL, Butcher EC: A cell‑surface molecule involved in organ‑specific homing of lymphocytes. Nature. 1983·Jul·7; 304:30‑34. <·PMID:·6866086·>
• Mannering SI, Cheers C: Interleukin‑2 and loss of immunity in experimental Mycobacterium avium infection. Infect·Immun. 2002·Jan; 70(1):27‑35. <·PMID:·11748160·>
• Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R: The type and frequency of immunoregulatory CD4+ T‑cells govern the efficacy of antigen‑specific immunotherapy in nonobese diabetic mice. Diabetes. 2007·May; 56(5):1395‑402. <·PMID:·17317763·>
• Richards H, Longhi MP, Wright K, Gallimore A, Ager A: CD62L (L‑selectin) down‑regulation does not affect memory T cell distribution but failure to shed compromises anti‑viral immunity. J·Immunol. 2008·Jan·1; 180(1):198‑206. <·PMID:·18097020·>
• ten Bruggencate SJ, Hillyer LM, Woodward BD: The proportion of CD45RA(+)CD62L(+) (quiescent‑phenotype) T cells within the CD8(+) subset increases in advanced weight loss in the protein‑ or energy‑deficient weanling mouse. J·Nutr. 2001·Dec; 131(12):3266‑9. <·PMID:·11739878·>
• Xu H, Manivannan A, Crane I, Dawson R, Liversidge J: Critical but divergent roles for CD62L and CD44 in directing blood monocyte trafficking in vivo during inflammation. Blood. 2008·Aug·15; 112(4):1166‑74. <·PMID:·18391078·>

Available Safety Data Sheets

CyFlow™ monoclonal antibodies SDS CA EN

Available Technical Data Sheets

CyFlow™ CD62L FITC (MEL-14) AX041427 TDS (US)